DelveInsight

Pertussis Market

DelveInsight’s “Pertussis Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Pertussis, historical and forecasted epidemiology as well as the Pertussis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Pertussis market report provides current treatment practices, emerging drugs, Pertussis market share of the individual therapies, current and forecasted Pertussis market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Pertussis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Pertussis Market Outlook

According to DelveInsight, Pertussis market in 7MM is expected to change in the study period 2017-2030.

The Pertussis market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Pertussis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Pertussis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

Request for sample pages @ Pertussis Market Outlook 

Table of contents

1. Key Insights

2. Executive Summary of Pertussis

3. Competitive Intelligence Analysis for Pertussis

4. Pertussis: Market Overview at a Glance

4.1. Pertussis Total Market Share (%) Distribution in 2017

4.2. Pertussis Total Market Share (%) Distribution in 2030

5. Pertussis: Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms

5.3. Pathophysiology

5.4. Risk Factors

5.5. Diagnosis

6. Pertussis Patient Journey

7. Pertussis Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Pertussis Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Pertussis Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Pertussis Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Pertussis Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Pertussis Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Pertussis Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Pertussis Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Pertussis Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Pertussis Treatment and Management

8.2. Pertussis Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Pertussis Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Pertussis: Seven Major Market Analysis

13.1. Key Findings

13.2. Pertussis Market Size in 7MM

13.3. Pertussis Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Pertussis Total Market Size in the United States

15.1.2. Pertussis Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Pertussis Total Market Size in Germany

15.3.2. Pertussis Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Pertussis Total Market Size in France

15.4.2. Pertussis Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Pertussis Total Market Size in Italy

15.5.2. Pertussis Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Pertussis Total Market Size in Spain

15.6.2. Pertussis Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Pertussis Total Market Size in the United Kingdom

15.7.2. Pertussis Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Pertussis Total Market Size in Japan

15.8.3. Pertussis Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Pertussis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

*The table of contents is not exhaustive; the final content may vary. 

Request for sample pages @ Pertussis Market Outlook 

https://themarketeagle.com/

By sthakur